Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
A multidisciplinary lifestyle program for metabolic syndrome-associated osteoarthritis: the "Plants for Joints" randomized controlled trial.
Walrabenstein W, Wagenaar CA, van de Put M, van der Leeden M, Gerritsen M, Twisk JWR, van der Esch M, van Middendorp H, Weijs PJM, Roorda LD, van Schaardenburg D. Walrabenstein W, et al. Osteoarthritis Cartilage. 2023 Nov;31(11):1491-1500. doi: 10.1016/j.joca.2023.05.014. Epub 2023 Jun 14. Osteoarthritis Cartilage. 2023. PMID: 37328047 Free article. Clinical Trial.
The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the "Plants for Joints" randomized controlled trial protocol.
Walrabenstein W, van der Leeden M, Weijs P, van Middendorp H, Wagenaar C, van Dongen JM, Nieuwdorp M, de Jonge CS, van Boheemen L, van Schaardenburg D. Walrabenstein W, et al. Trials. 2021 Oct 18;22(1):715. doi: 10.1186/s13063-021-05682-y. Trials. 2021. PMID: 34663431 Free PMC article.
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial.
Wagenaar CA, Walrabenstein W, van der Leeden M, Turkstra F, Gerritsen M, Twisk JWR, Boers M, van der Esch M, van Middendorp H, Weijs PJM, van Schaardenburg D. Wagenaar CA, et al. Among authors: walrabenstein w. RMD Open. 2024 Feb 27;10(1):e004025. doi: 10.1136/rmdopen-2023-004025. RMD Open. 2024. PMID: 38413171 Free PMC article.